Lodygin, D., V. Tarasov, A. Epanchintsev, C. Berking, T. Knyazeva, H. K├Ârner, P. Knyazev, J. Diebold and H. Hermeking: Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. In: Cell Cycle 7, 16, 2591-2600 (2008).
Tarasov, V., P. Jung, B. Verdoodt, D. Lodygin, A. Epanchintsev, A. Menssen, G. Meister and H. Hermeking: Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing - miR-34a is a p53 target that induces apoptosis and G(1)-arrest. In: Cell Cycle 6, 13, 1586-1593 (2007).
Menssen, A., A. Epanchintsev, D. Lodygin, N. Rezaei, P. Jung, B. Verdoodt, J. Diebold and H. Hermeking: c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1. In: Cell Cycle 6, 3, 339-352 (2007).
Korner, H., A. Epanchintsev, C. Berking, B. Schuler-Thurner, M. R. Speicher, A. Menssen and H. Hermeking: Digital karyotyping reveals frequent inactivation of the Dystrophin/DMD gene in malignant melanoma. In: Cell Cycle 6, 2, 189-198 (2007).
Epanchintsev, A., P. Jung, A. Menssen and H. Hermeking: Inducible microRNA expression by an all-in-one episomal vector system. In: Nucleic Acids Research 34, 18, Seq. No.: e119 (2006).
Lodygin, D., A. Epanchintsev, A. Menssen, J. Diebold and H. Hermeking: Functional epigenomics identifies genes frequently silenced in prostate cancer. In: Cancer Research 65, 10, 4218-4227 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.